Can't wait for optina data!
" our CRO discovered much of the drug product received at the clinical sites had been below the temperature requirement and may have been frozen for some period of time. "
But decided to use out of spec drug and not disclose until now? And AMPE now saying they can submit for approval without STEP data? Why did they even bother doing the study?
Way to go Mac.....
What would he say? With enough cash AMPE is not a short in the low 7s so why bother? The next PR will be spun the same as all prior ones. AMPE will release some of the data, but not enough to form a conclusion. They're working from a well established playbook Macalu established at ILE.
Re AF's father, nice work! There is a story from 6/25/89 in the LA Times about the son of a Richard Cavalli who was implicated in the death of a prostitute. Any comment?
Really? What was the improvement in visual acquity? This was an endpoint in the study but was not disclosed, hmmmmmmm.
Back short this pig. Thanks!
Naw, covered too early. Still made money, but not as much had i stayed short.
Aegis is a complete bucket shop. Embarrassing to do business with.
"If you want to see the effect of a non-equity road show, take a look at PRAN today. Used to be my second biggest holding, below AMPE. No longer.:
LOL.....Good luck with ampe....
They actually raised $63 million after fees (read the MArch 5 PR).
To the point on factory expenses, scampio said the renovations would cost 7 million (read the Dec. 16 PR).
They raised the extra money because they knew this kind of funding for biotechs like this will close soon, and they wanted to the cash. I'm just sorry i covered in the low 7s. Still made money, but there you go....